VMP 39710211000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Dornase alfa 2.5mg/2.5ml nebuliser liquid ampoules
BNF code 0307000K0AAAAAA
Virtual Therapeutic Moiety Dornase alfa
Date identifier became valid 26 May 2021
Previous product identifier 320921007
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 1 Feb 2010
Previous name Dornase alfa 1mg/ml nebuliser liquid 2.5ml ampoules
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 2.500
Unit dose form units ml
Unit dose unit of measure ampoule
Virtual Product Ingredient
Ingredient Dornase alfa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 1.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutionnebuliser.inhalation
Dose Form
Formulation Nebuliser liquid
Drug Route
Route Inhalation
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Pulmozyme 2.5mg nebuliser liquid 2.5ml ampoules (Roche Products Ltd)
Virtual Medicinal Product Packs
Dornase alfa 2.5mg/2.5ml nebuliser liquid ampoules 30 ampoule
Dornase alfa 2.5mg/2.5ml nebuliser liquid ampoules 6 ampoule

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback